Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nisha Singh

Showing results (251-260 of 264) with videos related to

Pageof 27
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 16, 2023
A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary Thyroid CarcinomaAngela Chou, Min Ru Qiu, Henry Crayton, et al.
Nature Microbiology|July 12, 2024
Bacterial reprogramming of tick metabolism impacts vector fitness and susceptibility to infectionSourabh Samaddar, Agustin Rolandelli, Anya J O'Neal, et al.
Lancet (London, England)|June 12, 2022
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trialGrace Li, Federica Cappuccini, Natalie G Marchevsky, et al.
The New England Journal of Medicine|October 29, 2025
Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A VaccineNaina McCann, Margarete Paganotti Vicentine, Narges Ebrahimi, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Tick extracellular vesicles undermine epidermal wound healing during hematophagyLiron Marnin, Luisa M Valencia, Haikel N Bogale, et al.
The Journal of Investigative Dermatology|September 7, 2025
Tick Extracellular Vesicles Alter Epidermal Keratinocyte FunctionLiron Marnin, Luisa M Valencia, Haikel N Bogale, et al.
The Journal of Infection|June 18, 2023
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trialEimear Kelly, Melanie Greenland, Philip C S de Whalley, et al.
Lancet (London, England)|August 9, 2021
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trialXinxue Liu, Robert H Shaw, Arabella S V Stuart, et al.
The Lancet. Respiratory Medicine|June 11, 2022
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trialRobert H Shaw, Xinxue Liu, Arabella S V Stuart, et al.
The Journal of Infection|April 7, 2023
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccinesRobert H Shaw, Melanie Greenland, Arabella S V Stuart, et al.
Pageof 27

Showing results (251-260 of 264) with videos related to

Sort By:
Pageof 27
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 16, 2023
A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary Thyroid CarcinomaAngela Chou, Min Ru Qiu, Henry Crayton, et al.
Nature Microbiology|July 12, 2024
Bacterial reprogramming of tick metabolism impacts vector fitness and susceptibility to infectionSourabh Samaddar, Agustin Rolandelli, Anya J O'Neal, et al.
Lancet (London, England)|June 12, 2022
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trialGrace Li, Federica Cappuccini, Natalie G Marchevsky, et al.
The New England Journal of Medicine|October 29, 2025
Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A VaccineNaina McCann, Margarete Paganotti Vicentine, Narges Ebrahimi, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Tick extracellular vesicles undermine epidermal wound healing during hematophagyLiron Marnin, Luisa M Valencia, Haikel N Bogale, et al.
The Journal of Investigative Dermatology|September 7, 2025
Tick Extracellular Vesicles Alter Epidermal Keratinocyte FunctionLiron Marnin, Luisa M Valencia, Haikel N Bogale, et al.
The Journal of Infection|June 18, 2023
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trialEimear Kelly, Melanie Greenland, Philip C S de Whalley, et al.
Lancet (London, England)|August 9, 2021
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trialXinxue Liu, Robert H Shaw, Arabella S V Stuart, et al.
The Lancet. Respiratory Medicine|June 11, 2022
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trialRobert H Shaw, Xinxue Liu, Arabella S V Stuart, et al.
The Journal of Infection|April 7, 2023
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccinesRobert H Shaw, Melanie Greenland, Arabella S V Stuart, et al.
Pageof 27